Table-IV.
Group | Nausea | Headache | Vertigo | Total adverse reactions |
---|---|---|---|---|
Control group | 2 (5.7) | 1 (2.9) | 1 (2.9) | 4 (11.4) |
Treatment group | 1 (2.9) | 2 (5.7) | 2 (5.7) | 5 (14.3) |
Group | Nausea | Headache | Vertigo | Total adverse reactions |
---|---|---|---|---|
Control group | 2 (5.7) | 1 (2.9) | 1 (2.9) | 4 (11.4) |
Treatment group | 1 (2.9) | 2 (5.7) | 2 (5.7) | 5 (14.3) |